| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1205 | Calcium Ionophore A23187 | Ionophore highly selective for Ca , potentiating responses to NMDA but not quisqualate |
|
| DCC1206 | Camostat | Transmembrane protease serine 2 (TMPRSS2) inhibitor for the treatment of chronic pancreatitis and postoperative gastric reflux, blocking SARS-CoV-2 replication in TMPRSS2-expressing human cells |
|
| DCC1207 | Cand1-cullin1 Destabilizer C60 | Novel destabilizer of CAND1-Cullin1 interaction, inducing a p53-stress response pathway |
|
| DCC1208 | Cannabigerolic Acid | Natural cannabinoid precursor |
|
| DCC1209 | Cannabigerovarinic Acid | Natural cannabinoid precursor |
|
| DCC1210 | Cap Kl1 | Novel self-assembling lysine-rich cationic amphipathic peptide (CAP) |
|
| DCC1211 | Capravirine | Reverse-transcriptase_inhibitor>Non-nucleoside reverse transcriptase inhibitor |
|
| DCC1212 | Capreomycin | Broad spectrum antibiotic used in the therapy of drug resistant tuberculosis as a second line agent |
|
| DCC1213 | Caramiphen | Antimuscarinic and anticholinergic, acting as an antagonist of NMDA receptor |
|
| DCC1214 | Carazostatin | Antioxidant, free radical scavenger and potent inhibitor of lipid peroxidation |
|
| DCC1215 | Carbavance | Mixture of Meropenem and vaborbactam for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria |
|
| DCC1216 | Carboetomidate | Analog of etomidate that interacts weakly with 11β-hydroxylase |
|
| DCC1217 | Carboxy-pyridostatin | Novel fluorescent probe targeting of G-quadruplex structures and trapping cytoplasmic RNA G-quadruplex structures in cells |
|
| DCC1218 | Cardiosulfa | Inducer of deformation in Zebrafish>Zebrafish through the AhR-mediated, CYP1A-independent pathway |
|
| DCC1219 | Carm1-in-2 | Novel inhibitor of full-length GST-tagged CARM-1 |
|
| DCC1220 | Carm1-in-9 | Novel potent inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1) |
|
| DCC1221 | Carmegliptin | Novel, potent, long-acting, selective, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4) with hypoglycemic activity |
|
| DCC1222 | Carminomycin | Anthracycline antineoplastic antibiotic, intercalating into DNA and interacting with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. |
|
| DCC1223 | Carmoterol | Long acting ß2-adrenoreceptor agonist (LABA) |
|
| DCC1224 | Carotegrast | Novel orally available α4 integrin receptor inhibitor |
|
| DCC1225 | Caroxazone | Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI) |
|
| DCC1226 | Carzelesin | DNA minor groove alkylating agent, alkylating N3 of adenine in a consensus sequence 5'-(A/T)(A/T)A* |
|
| DCC1227 | Cas9 Inhibitor 85 | Novel Cas9 Inhibitor, direct binding to apo-Cas9, preventing Cas9:gRNA complex formation |
|
| DCC1228 | Caspofungin | The first inhibitor of fungal (1→3)-β-D-glucan synthesis |
|
| DCC1229 | Casuarinin | Natural potent neutrophil elastase (NE) inhibitor with an IC 50 value of 2.79 ± 0.07 μM |
|
| DCC1230 | Cat-5571 | Novel activator of autophagy for potential treatment of cystic fibrosis |
|
| DCC1231 | Cathepsin B Inhibitor-42 | Selective inhibitor of cathepsin B endopeptidase and exopeptidase activities |
|
| DCC1232 | Cathepsin B Inhinitor-17 | Selective inhibitor of cathepsin B endopeptidase and exopeptidase activities |
|
| DCC1233 | Cathepsin X Inhibitor Z9 | Novel selective reversible inhibitor of cathepsin X |
|
| DCC1234 | Cavalpha2delta-1 Ligand 16rr | Novel ligand of voltage-gated calcium channel α2δ-1 subunit (Cavα2δ-1) |
|
